|
Speciality Spotlight
Transfusion
Medicine
G
Barosi, M Marchetti, NL Liberato (IRCCS Policlinico
S -Matteo, Pavia, Italy)
Cost-effectiveness of Recombinant Human Erythropoietin in the Prevention
of Chemotherapy-induced Anaemia.
Br.
J Cancer 78:781-787,
1998.
As it is currently used, rHuEPO is not
cost-effective for the treatment of
chemotherapy-induced anaemia.
It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.
It is a long established fact that the read will been distracted by there readable an important content. It is a long established fact that the read will been distracted.
